The effect of the Covid-19 shutdown on glycemic testing and control

BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic caused a halt to in-person ambulatory care. We evaluated how the reduction in access to care affected HbA1c testing and patient HbA1c levels. METHODS: HbA1c data from 11 institutions were extracted to compare testing volume and the percent...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Anu, Greene, Dina N., Chambliss, Allison B., Farnsworth, Christopher W., French, Deborah, Herman, Daniel S., Kavsak, Peter A., Merrill, Anna E., (Margaret) Lo, Sheng-Ying, Lyon, Martha E., Winston-McPherson, Gabrielle, Pearson, Lauren N., SoRelle, Jeffrey A., Waring, Avantika C., Schmidt, Robert L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080532/
https://www.ncbi.nlm.nih.gov/pubmed/33932408
http://dx.doi.org/10.1016/j.cca.2021.04.018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080532/
https://www.ncbi.nlm.nih.gov/pubmed/33932408
http://dx.doi.org/10.1016/j.cca.2021.04.018

Ejemplares similares